Favorable outcome of allogeneic bone marrow transplantation in the treatment of pediatric osteosarcoma in the metastatic stage - clinical observation
- Authors: Bogatyrev S.
- Issue: Vol 1, No 2 (2006)
- Pages: 25-26
- Section: Cell technology
- URL: https://genescells.ru/2313-1829/article/view/205282
- DOI: https://doi.org/10.23868/gc205282
- ID: 205282
Cite item
Open Access
Access granted
Full Text
About the authors
S. Bogatyrev
Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation
References
- Weiden P.L., Flournoy N., Thomas E.D. et al. Antileukemic effect of graft— versus-host disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med. 1979, 300:1068-73.
- Moscovitch M„ Slavin S. Anti-tumor effects of allogeneic bone marrow transplantation in [NZB X NZW)F1 hybrids with spontaneous lymphosarcoma. J. Immunol. 1984; 132(2): 997-1000.
- Barnes D.W.H., Loutit J.F. Treatment of murine leukaemia with X-rays and homologous bone marrow. Br. J. Haematol. 1957; 3: 241-52
- Carnevale-Schianca F., Ricchiardi A., Capaldi A. et al. Allogeneic hemopoietic stem cell transplantation in solid tumors. Transplant. Proc. 2005; 37(6): 2664-6.
- Baron F., Maris M.B., Sandmaier B.M. et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J. Clin. Oncol. 2005; 23(9): 1993-2003.
- Wang L.L. Biology of osteogenic sarcoma. Cancer J. 2005; 11(4): 294-305.
- Nagarajan R., Clohisy D., Weigel B. New paradigms for therapy for osteosarcoma. Curr. Oncol. Rep. 2005; 7(6): 410-4.
Supplementary files
